Award
National Cancer Institute 5R61CA291117-02
Evolved Molecules that Destroy Cancer Relevant Proteins
Recipient
FOUNDATION FOR APPLIED MOLECULAR EVOLUTN
Award Amount
$215,564.00
Ceiling
$215,564.00
Awarded
September 10, 2025
Identifier
5R61CA291117-02
Award for developing molecular tools to target cancer-related proteins, funded by the National Cancer Institute.
Description
The project involves developing reagents (AEGISbodies and AEGISCleavers) that bind and cleave target proteins, with applications in cancer diagnostics and therapy. The project aims to create innovative molecular tools targeting PD-L1 for cancer therapy.